secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protalix BioTherapeutics, Inc. (PLX)
CIK:        0001006281
Form:       8-K
Filed at:   2022-12-27T23:59:59+00:00
Accession:  0001558370-22-018990
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protalix BioTherapeutics sets March 22, 2023 for TASE delisting; will remain on NYSE American
--------------------------------------------------------------------------------

- Delisting from Tel Aviv Stock Exchange effective March 22, 2023; last trading day March 20, 2023.
- Common stock will continue to be listed and trade on NYSE American under symbol PLX.
- Israeli shareholders urged to contact their brokers to transfer shares to a NYSE American-based account.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006281/000155837022018990/0001558370-22-018990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006281/000155837022018990/plx-20221227x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer